Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma 2019-02-28 08:30
Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards 2019-02-27 12:00
Blackford Analysis Commended by Frost & Sullivan for its Visionary Implementation of Platform-based Approaches in the Medical Imaging Space 2019-02-26 22:00
Cachet Asset Management to Lead the Latest Round of Funding for ProTom International Holding Company 2019-02-26 19:22
Focusing on Advanced Laboratory Instruments and Equipment, Building an All-around Live-action Space -- 2019 InnoLAB Salon Formally Kicked Off 2019-02-26 15:00
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million 2019-02-26 08:23
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019 2019-02-26 05:16
Top 3 Growth Opportunities for Digital Pathology-enabling Technology Companies 2019-02-26 03:13
Mallinckrodt Announces Extracorporeal Photopheresis (ECP) Research Collaboration Agreement With Transimmune AG 2019-02-25 22:00
Texas Cardiac Arrhythmia Institute at St. David's Medical Center enrolling patients to test stroke-reducing device 2019-02-25 10:08
Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing 2019-02-22 15:02
PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU 2019-02-22 06:13
Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Cipla and Wellthy Therapeutics Announce Partnership to Offer Digital Therapeutics for Diabetes and Cardiovascular Diseases 2019-02-21 07:30
Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey 2019-02-20 19:07
Future of Clinical Laboratories: How to Adapt Your Strategy to the Declining Reimbursements and Be Successful 2019-02-19 21:20
Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method 2019-02-19 21:00
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2019 Financial Results 2019-02-19 19:00
1 430 431 432 433 434 531